Drastic morphological and molecular differences between lymph node micrometastatic tumors and macrometastatic tumors of lung adenocarcinoma

Nao Aramaki, Genichiro Ishii, Eiji Yamada, Masahiro Morise, Keiju Aokage, Motohiro Kojima, Tomoyuki Hishida, Junji Yoshida, Norihiko Ikeda, Masahiro Tsuboi, Atsushi Ochiai

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose: The expansion of micrometastatic tumors to macrometastatic ones is thought to be tightly regulated by several microenvironmental factors. The aim of this study was to elucidate the morphological and phenotypical differences between micrometastatic and macrometastatic tumors. Method: We first examined the morphological characteristics of 66 lymph node (LN) micrometastatic tumors (less than 2 mm in size) and 51 macrometastatic tumors (more than 10 mm in size) in 42 lung adenocarcinoma cases. Then, we evaluated the expression level of E-cadherin, S100A4, ALDH1, and Geminin in cancer cells and the number of smooth muscle actin (SMA), CD34, and CD204 (+) stromal cells in the primary tumors, matched micrometastatic tumors, and macrometastatic tumors (n = 34, each). Results: Tumor budding reflects the process of EMT, and stromal reactions were observed more frequently in macrometastatic tumors (P < 0.001). E-cadherin staining score for the micrometastatic tumors was significantly higher than that for the primary tumors (P < 0.001). In contrast, the E-cadherin staining score for the macrometastatic tumors was significantly lower than that for the micrometastatic tumors (P = 0.017). As for the stromal cells, the numbers of SMA (+) fibroblasts, CD34 (+) microvessels, and CD204 (+) macrophages were significantly higher for the macrometastatic tumors and primary tumors than for the micrometastatic tumors (P < 0.001, all). Conclusion: The present study clearly showed that dynamic microenvironmental changes (e.g., EMT-related changes in cancer cells and structural changes in stromal cells) occur during the growth of micrometastases into macrometastases.

Original languageEnglish
Pages (from-to)37-46
Number of pages10
JournalJournal of Cancer Research and Clinical Oncology
Volume142
Issue number1
DOIs
Publication statusPublished - 2016 Jan 1
Externally publishedYes

Fingerprint

Lymph Nodes
Neoplasms
Cadherins
Stromal Cells
Adenocarcinoma of lung
Smooth Muscle
Actins
Geminin
Cell Count
Staining and Labeling
Neoplasm Micrometastasis
Microvessels
Fibroblasts
Macrophages

Keywords

  • Cancer microenvironment
  • Lung adenocarcinoma
  • Macrometastasis
  • Micrometastasis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Drastic morphological and molecular differences between lymph node micrometastatic tumors and macrometastatic tumors of lung adenocarcinoma. / Aramaki, Nao; Ishii, Genichiro; Yamada, Eiji; Morise, Masahiro; Aokage, Keiju; Kojima, Motohiro; Hishida, Tomoyuki; Yoshida, Junji; Ikeda, Norihiko; Tsuboi, Masahiro; Ochiai, Atsushi.

In: Journal of Cancer Research and Clinical Oncology, Vol. 142, No. 1, 01.01.2016, p. 37-46.

Research output: Contribution to journalArticle

Aramaki, Nao ; Ishii, Genichiro ; Yamada, Eiji ; Morise, Masahiro ; Aokage, Keiju ; Kojima, Motohiro ; Hishida, Tomoyuki ; Yoshida, Junji ; Ikeda, Norihiko ; Tsuboi, Masahiro ; Ochiai, Atsushi. / Drastic morphological and molecular differences between lymph node micrometastatic tumors and macrometastatic tumors of lung adenocarcinoma. In: Journal of Cancer Research and Clinical Oncology. 2016 ; Vol. 142, No. 1. pp. 37-46.
@article{eeaac8e047664ec58130a66a2ea76d70,
title = "Drastic morphological and molecular differences between lymph node micrometastatic tumors and macrometastatic tumors of lung adenocarcinoma",
abstract = "Purpose: The expansion of micrometastatic tumors to macrometastatic ones is thought to be tightly regulated by several microenvironmental factors. The aim of this study was to elucidate the morphological and phenotypical differences between micrometastatic and macrometastatic tumors. Method: We first examined the morphological characteristics of 66 lymph node (LN) micrometastatic tumors (less than 2 mm in size) and 51 macrometastatic tumors (more than 10 mm in size) in 42 lung adenocarcinoma cases. Then, we evaluated the expression level of E-cadherin, S100A4, ALDH1, and Geminin in cancer cells and the number of smooth muscle actin (SMA), CD34, and CD204 (+) stromal cells in the primary tumors, matched micrometastatic tumors, and macrometastatic tumors (n = 34, each). Results: Tumor budding reflects the process of EMT, and stromal reactions were observed more frequently in macrometastatic tumors (P < 0.001). E-cadherin staining score for the micrometastatic tumors was significantly higher than that for the primary tumors (P < 0.001). In contrast, the E-cadherin staining score for the macrometastatic tumors was significantly lower than that for the micrometastatic tumors (P = 0.017). As for the stromal cells, the numbers of SMA (+) fibroblasts, CD34 (+) microvessels, and CD204 (+) macrophages were significantly higher for the macrometastatic tumors and primary tumors than for the micrometastatic tumors (P < 0.001, all). Conclusion: The present study clearly showed that dynamic microenvironmental changes (e.g., EMT-related changes in cancer cells and structural changes in stromal cells) occur during the growth of micrometastases into macrometastases.",
keywords = "Cancer microenvironment, Lung adenocarcinoma, Macrometastasis, Micrometastasis",
author = "Nao Aramaki and Genichiro Ishii and Eiji Yamada and Masahiro Morise and Keiju Aokage and Motohiro Kojima and Tomoyuki Hishida and Junji Yoshida and Norihiko Ikeda and Masahiro Tsuboi and Atsushi Ochiai",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/s00432-015-1996-0",
language = "English",
volume = "142",
pages = "37--46",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Drastic morphological and molecular differences between lymph node micrometastatic tumors and macrometastatic tumors of lung adenocarcinoma

AU - Aramaki, Nao

AU - Ishii, Genichiro

AU - Yamada, Eiji

AU - Morise, Masahiro

AU - Aokage, Keiju

AU - Kojima, Motohiro

AU - Hishida, Tomoyuki

AU - Yoshida, Junji

AU - Ikeda, Norihiko

AU - Tsuboi, Masahiro

AU - Ochiai, Atsushi

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Purpose: The expansion of micrometastatic tumors to macrometastatic ones is thought to be tightly regulated by several microenvironmental factors. The aim of this study was to elucidate the morphological and phenotypical differences between micrometastatic and macrometastatic tumors. Method: We first examined the morphological characteristics of 66 lymph node (LN) micrometastatic tumors (less than 2 mm in size) and 51 macrometastatic tumors (more than 10 mm in size) in 42 lung adenocarcinoma cases. Then, we evaluated the expression level of E-cadherin, S100A4, ALDH1, and Geminin in cancer cells and the number of smooth muscle actin (SMA), CD34, and CD204 (+) stromal cells in the primary tumors, matched micrometastatic tumors, and macrometastatic tumors (n = 34, each). Results: Tumor budding reflects the process of EMT, and stromal reactions were observed more frequently in macrometastatic tumors (P < 0.001). E-cadherin staining score for the micrometastatic tumors was significantly higher than that for the primary tumors (P < 0.001). In contrast, the E-cadherin staining score for the macrometastatic tumors was significantly lower than that for the micrometastatic tumors (P = 0.017). As for the stromal cells, the numbers of SMA (+) fibroblasts, CD34 (+) microvessels, and CD204 (+) macrophages were significantly higher for the macrometastatic tumors and primary tumors than for the micrometastatic tumors (P < 0.001, all). Conclusion: The present study clearly showed that dynamic microenvironmental changes (e.g., EMT-related changes in cancer cells and structural changes in stromal cells) occur during the growth of micrometastases into macrometastases.

AB - Purpose: The expansion of micrometastatic tumors to macrometastatic ones is thought to be tightly regulated by several microenvironmental factors. The aim of this study was to elucidate the morphological and phenotypical differences between micrometastatic and macrometastatic tumors. Method: We first examined the morphological characteristics of 66 lymph node (LN) micrometastatic tumors (less than 2 mm in size) and 51 macrometastatic tumors (more than 10 mm in size) in 42 lung adenocarcinoma cases. Then, we evaluated the expression level of E-cadherin, S100A4, ALDH1, and Geminin in cancer cells and the number of smooth muscle actin (SMA), CD34, and CD204 (+) stromal cells in the primary tumors, matched micrometastatic tumors, and macrometastatic tumors (n = 34, each). Results: Tumor budding reflects the process of EMT, and stromal reactions were observed more frequently in macrometastatic tumors (P < 0.001). E-cadherin staining score for the micrometastatic tumors was significantly higher than that for the primary tumors (P < 0.001). In contrast, the E-cadherin staining score for the macrometastatic tumors was significantly lower than that for the micrometastatic tumors (P = 0.017). As for the stromal cells, the numbers of SMA (+) fibroblasts, CD34 (+) microvessels, and CD204 (+) macrophages were significantly higher for the macrometastatic tumors and primary tumors than for the micrometastatic tumors (P < 0.001, all). Conclusion: The present study clearly showed that dynamic microenvironmental changes (e.g., EMT-related changes in cancer cells and structural changes in stromal cells) occur during the growth of micrometastases into macrometastases.

KW - Cancer microenvironment

KW - Lung adenocarcinoma

KW - Macrometastasis

KW - Micrometastasis

UR - http://www.scopus.com/inward/record.url?scp=84953638689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953638689&partnerID=8YFLogxK

U2 - 10.1007/s00432-015-1996-0

DO - 10.1007/s00432-015-1996-0

M3 - Article

C2 - 26084978

AN - SCOPUS:84953638689

VL - 142

SP - 37

EP - 46

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 0171-5216

IS - 1

ER -